Diffusion Pharmaceuticals Inc.
(NASDAQ CM: DFFN)
Rigrodsky Law, P.A. is investigating Diffusion Pharmaceuticals Inc. (“Diffusion”) regarding possible breaches of fiduciary duties and other violations of law related to Diffusion’s agreement to merge with EIP Pharma Inc.